Back to results
US 2009/0263334 A1Published application
Cyclic Glycyl-2-Allyl Proline Improves Cognitive Performance in Impaired Animals
OwnerMike John Bickerdike, Jlan Guaninventors
Life of this patent
Estimating the term…
Abstract
Embodiments of this invention provide methods for therapeutic use of cyclic G-2-Allyl Proline to treat cognitive disorders as well as manufacture of medicaments including tablets, capsules, injectable solutions that are useful for treatment of such conditions.
Claims19
A method for treating cognitive impairment in a mammal in need thereof, comprising:
- administering a pharmaceutically effective amount of cyclic Glycyl-2Allyl Proline (cG-2AllylP) to said mammal.
A method for treating an animal having a disorder characterized by cognitive impairment, comprising administering to said animal, a composition comprising an effective amount of cG-2AllylP.
Dependencies are inferred from the claim text.